InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Plesha Scott M., Chief Executive Officer. Insider active across 2 companies, notably Pelthos Therapeutics Inc.. In total, 5 disclosures have been published. Activity tracked since 27 January 2022. The latest transaction was disclosed on 2 July 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
83,678 shares0Common StockSEC:0001919246-26-000044:0
83,678 shares0Common StockSEC:0001919246-26-000044
345,127 shares0Common StockSEC:0001103021-22-000070:0
21,050 shares0Common StockSEC:0001103021-22-000016:0
21,050 shares0Common StockSEC:0001103021-22-000016
5 of 5 declarations
About Plesha Scott M.
Scott M. Plesha is the CEO and President of Pelthos Therapeutics Inc. and BioDelivery Sciences International Inc. In these roles, he is responsible for the strategic and operational direction of the companies, which focus on developing innovative therapies. Mr. Plesha plays a crucial role in setting growth objectives and overseeing daily operations.
